Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (331-340 of 2,280) with videos related to

Pageof 228
Sort By:
European Heart Journal|September 12, 2019
Leadership in Cardiovascular MedicineAaron Ali Shaikh, Deepak L Bhatt, Ankur Kalra
Journal of the American College of Cardiology|April 8, 2017
Coronary CTA in the Evaluation of Stable Chest Pain: Clear Benefits, But Not for AllRon Blankstein, Márcio Sommer Bittencourt, Deepak L Bhatt
European Heart Journal|October 12, 2017
The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrumCian P McCarthy, Gabriel Steg, Deepak L Bhatt
The Lancet. Digital Health|December 17, 2020
Artificial intelligence in medical imaging: switching from radiographic pathological data to clinically meaningful endpointsOhad Oren, Bernard J Gersh, Deepak L Bhatt
JACC. Basic to Translational Science|March 26, 2025
Emerging Pathways of Action of Eicosapentaenoic Acid (EPA)Deepak L Bhatt, Peter Libby, R Preston Mason
European Journal of Heart Failure|April 12, 2024
Reply to 'The pharmacist ally in heart failure: Useful when involved'Craig J Beavers, Deepak L Bhatt, Gad Gotter
Cleveland Clinic Journal of Medicine|August 18, 2006
Using statins to treat inflammation in acute coronary syndromes: Are we there yet?Mehdi H Shishehbor, Taral Patel, Deepak L Bhatt
Expert Opinion on Drug Safety|July 13, 2021
Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglyceridesManan Pareek, R Preston Mason, Deepak L Bhatt
The New England Journal of Medicine|April 25, 2019
Cardiovascular Risk Reduction with Icosapent Ethyl. ReplyDeepak L Bhatt, P Gabriel Steg, Michael Miller
JAMA Cardiology|April 27, 2017
The Management of Antiplatelet and Antithrombotic Regimens in Patients With Mechanical Valves Undergoing Percutaneous Coronary Intervention: A Forgotten Cohort?Cian P McCarthy, Subodh Verma, Deepak L Bhatt
Pageof 228

Showing results (331-340 of 2,280) with videos related to

Sort By:
Pageof 228
European Heart Journal|September 12, 2019
Leadership in Cardiovascular MedicineAaron Ali Shaikh, Deepak L Bhatt, Ankur Kalra
Journal of the American College of Cardiology|April 8, 2017
Coronary CTA in the Evaluation of Stable Chest Pain: Clear Benefits, But Not for AllRon Blankstein, Márcio Sommer Bittencourt, Deepak L Bhatt
European Heart Journal|October 12, 2017
The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrumCian P McCarthy, Gabriel Steg, Deepak L Bhatt
The Lancet. Digital Health|December 17, 2020
Artificial intelligence in medical imaging: switching from radiographic pathological data to clinically meaningful endpointsOhad Oren, Bernard J Gersh, Deepak L Bhatt
JACC. Basic to Translational Science|March 26, 2025
Emerging Pathways of Action of Eicosapentaenoic Acid (EPA)Deepak L Bhatt, Peter Libby, R Preston Mason
European Journal of Heart Failure|April 12, 2024
Reply to 'The pharmacist ally in heart failure: Useful when involved'Craig J Beavers, Deepak L Bhatt, Gad Gotter
Cleveland Clinic Journal of Medicine|August 18, 2006
Using statins to treat inflammation in acute coronary syndromes: Are we there yet?Mehdi H Shishehbor, Taral Patel, Deepak L Bhatt
Expert Opinion on Drug Safety|July 13, 2021
Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglyceridesManan Pareek, R Preston Mason, Deepak L Bhatt
The New England Journal of Medicine|April 25, 2019
Cardiovascular Risk Reduction with Icosapent Ethyl. ReplyDeepak L Bhatt, P Gabriel Steg, Michael Miller
JAMA Cardiology|April 27, 2017
The Management of Antiplatelet and Antithrombotic Regimens in Patients With Mechanical Valves Undergoing Percutaneous Coronary Intervention: A Forgotten Cohort?Cian P McCarthy, Subodh Verma, Deepak L Bhatt
Pageof 228